{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:00:57Z","timestamp":1761541257516,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.brachy.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T16:15:56Z","timestamp":1437236156000},"page":"795-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"David R.","family":"Raleigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Tomlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Adam","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve E.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuto","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Mack","family":"Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chow","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2015.06.004_bib1","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2015.06.004_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(03)00081-6","article-title":"High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity","volume":"56","author":"Yoshioka","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijrobp.2007.12.026","article-title":"A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer","volume":"72","author":"Corner","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brachy.2008.09.004","article-title":"Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy","volume":"8","author":"Ghadjar","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.06.004_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2008.12.051","article-title":"Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer","volume":"75","author":"Konishi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e3181b9cd2f","article-title":"High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer","volume":"33","author":"Martinez","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2015.06.004_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ijrobp.2010.09.006","article-title":"High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a phase II trial","volume":"82","author":"Barkati","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.06.004_bib12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.ju.0000061964.49961.55","article-title":"Health related quality of life in men with prostate cancer","volume":"169","author":"Penson","year":"2003","journal-title":"J Urol"},{"issue":"4A Suppl","key":"10.1016\/j.brachy.2015.06.004_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0090-4295(99)80325-2","article-title":"How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium","volume":"49","author":"Altwein","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archfami.2.5.487","article-title":"A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team","volume":"2","author":"Wasson","year":"1993","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.brachy.2015.06.004_bib15","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.2001.19.6.1619","article-title":"Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer","volume":"19","author":"Madalinska","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2015.06.004_bib16","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/cncr.22676","article-title":"Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer","volume":"109","author":"Litwin","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.06.004_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-5347(05)67818-4","article-title":"Quality of life outcomes after brachytherapy for early stage prostate cancer","volume":"163","author":"Brandeis","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.06.004_bib18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0022-5347(05)65870-3","article-title":"Quality of life after treatment for localized prostate cancer: differences based on treatment modality","volume":"166","author":"Davis","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.06.004_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.21198","article-title":"The role of anxiety in prostate carcinoma: a structured review of the literature","volume":"104","author":"Dale","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.06.004_bib20","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1002\/cncr.24544","article-title":"Partnership and outcomes in men with prostate cancer","volume":"115","author":"Bergman","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.06.004_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: a systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.brachy.2015.06.004_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2004.05.007","article-title":"Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy","volume":"3","author":"Hsu","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.06.004_bib23","first-page":"1549","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.brachy.2015.06.004_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.brachy.2015.06.004_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/(SICI)1098-2388(199711\/12)13:6<461::AID-SSU11>3.0.CO;2-W","article-title":"Quality of life after permanent prostate implant","volume":"13","author":"Arterbery","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.brachy.2015.06.004_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(99)00355-7","article-title":"A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer","volume":"46","author":"Lee","year":"2000","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.brachy.2015.06.004_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(98)00457-9","article-title":"Changes in quality of life following treatment for early prostate cancer","volume":"53","author":"Clark","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2015.06.004_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.clon.2014.06.012","article-title":"Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy","volume":"26","author":"Choudhury","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2015.06.004_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.radonc.2005.04.002","article-title":"Anatomy-based inverse planning dose optimization in HDR prostate implant: a toxicity study","volume":"75","author":"Mahmoudieh","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2015.06.004_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0360-3016(00)00632-5","article-title":"Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer","volume":"48","author":"Gelblum","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clon.2006.02.007","article-title":"Prediction of urinary symptoms after 125iodine prostate brachytherapy","volume":"18","author":"Kelly","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2015.06.004_bib32","first-page":"113","article-title":"Transperineal ultrasound-guided implantation of the prostate: morbidity and complications","volume":"137","author":"Blasko","year":"1991","journal-title":"Scand J\u00a0Urol Nephrol Suppl"},{"key":"10.1016\/j.brachy.2015.06.004_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/00365590310008668","article-title":"Variability of the International Prostate Symptom Score in men with lower urinary tract symptoms","volume":"37","author":"O'Connor","year":"2003","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.brachy.2015.06.004_bib34","first-page":"410","article-title":"Acute toxicity of conformal high dose interstitial brachytherapy boost in prostate cancer","volume":"53","author":"Soumarov\u00e1","year":"2006","journal-title":"Neoplasma"},{"key":"10.1016\/j.brachy.2015.06.004_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.brachy.2011.07.009","article-title":"Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy","volume":"11","author":"Cunha","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.06.004_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1999.17.2.517","article-title":"Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer","volume":"17","author":"Zelefsky","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2015.06.004_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0360-3016(00)00550-2","article-title":"Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer","volume":"47","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.06.004_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.06.004_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brachy.2013.10.006","article-title":"An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer","volume":"13","author":"Marina","year":"2014","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115005036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115005036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:08:24Z","timestamp":1761530904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472115005036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1538472115005036"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2015.06.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}